We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$19B
AUM Growth
+$1.28B
Cap. Flow
+$1.55B
Cap. Flow %
8.12%
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$89.1M
2
WEX icon
WEX
WEX
+$78.4M
3
BLK icon
Blackrock
BLK
+$73.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$71.9M
5
OMF icon
OneMain Financial
OMF
+$45.3M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 14.65%
3 Healthcare 12.11%
4 Consumer Discretionary 7.54%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACB
3001
Aurora Cannabis
ACB
$185M
$7K ﹤0.01%
111
+16
+17% +$1.14K
AGO icon
3002
Assured Guaranty
AGO
$3.34B
$7K ﹤0.01%
185
+62
+50% +$2.96K
ALE
3003
DELISTED
Allete
ALE
$7K ﹤0.01%
143
+43
+43% +$2.91K
ALEX
3004
DELISTED
Alexander & Baldwin
ALEX
$7K ﹤0.01%
339
+2
+0.6% +$41
AMTX icon
3005
Aemetis
AMTX
$124M
$7K ﹤0.01%
437
ASB icon
3006
Associated Banc-Corp
ASB
$5.91B
$7K ﹤0.01%
361
+37
+11% +$752
ASTS icon
3007
AST SpaceMobile
ASTS
$21.5B
$7K ﹤0.01%
700
ATR icon
3008
AptarGroup
ATR
$8.61B
$7K ﹤0.01%
60
-108
-64% -$14.2K
BDC icon
3009
Belden
BDC
$5.19B
$7K ﹤0.01%
136
-39
-22% -$2.09K
BLMN icon
3010
Bloomin' Brands
BLMN
$938M
$7K ﹤0.01%
308
CHRS icon
3011
Coherus Oncology
CHRS
$196M
$7K ﹤0.01%
441
CRON
3012
Cronos Group
CRON
$1.14B
$7K ﹤0.01%
1,312
+965
+278% +$6.56K
CWST icon
3013
Casella Waste Systems
CWST
$5.69B
$7K ﹤0.01%
94
-12
-11% -$846
DCTH icon
3014
Delcath Systems
DCTH
$524M
$7K ﹤0.01%
750
ECH icon
3015
iShares MSCI Chile ETF
ECH
$1.06B
$7K ﹤0.01%
300
EOLS icon
3016
Evolus
EOLS
$501M
$7K ﹤0.01%
1,000
EUSB icon
3017
iShares ESG Advanced Universal USD Bond ETF
EUSB
$712M
$7K ﹤0.01%
161
OPPE
3018
WisdomTree European Opportunities Fund
OPPE
$295M
$7K ﹤0.01%
211
FHB icon
3019
First Hawaiian
FHB
$3.35B
$7K ﹤0.01%
299
FSS icon
3020
Federal Signal
FSS
$7.83B
$7K ﹤0.01%
206
+1
+0.5% +$39
FTI icon
3021
TechnipFMC
FTI
$27.3B
$7K ﹤0.01%
1,000
-2,300
-70% -$16.5K
FXA icon
3022
Invesco CurrencyShares Australian Dollar Trust
FXA
$98M
$7K ﹤0.01%
100
GRP.U
3023
DELISTED
Granite Real Estate Investment Trust
GRP.U
$7K ﹤0.01%
100
GTX icon
3024
Garrett Motion
GTX
$5.57B
$7K ﹤0.01%
1,200
+38
+3% +$273
GXC icon
3025
State Street SPDR S&P China ETF
GXC
$482M
$7K ﹤0.01%
+69
New +$8.08K

Similar funds

Rockefeller Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.

  • Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
  • Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
  • Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
  • Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
  • Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
  • Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
  • Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.